A citation-based method for searching scientific literature

Josep Tabernero, Paulo M Hoff, Lin Shen, Atsushi Ohtsu, Manish A Shah, Karen Cheng, Chunyan Song, Haiyan Wu, Jennifer Eng-Wong, Katherine Kim, Yoon-Koo Kang. Lancet Oncol 2018
Times Cited: 195







List of shared articles



Times cited


HER2 in gastric adenocarcinoma: where do we stand today?
Khalil El Gharib, Makram Khoury, Hampig Raphael Kourie. Per Med 2022
0


Current status and future perspectives in HER2 positive advanced gastric cancer.
G Roviello, M Catalano, L F Iannone, L Marano, M Brugia, G Rossi, G Aprile, L Antonuzzo. Clin Transl Oncol 2022
1

Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients.
Emeline Orillard, Julie Henriques, Dewi Vernerey, Hamadi Almotlak, Fabien Calcagno, Francine Fein, Serge Fratté, Marine Jary, Elodie Klajer, Angelique Vienot,[...]. Front Oncol 2022
0

Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers.
Jeremy Chuang, Samuel Klempner, Kevin Waters, Katelyn Atkins, Joseph Chao, May Cho, Andrew Hendifar, Alexandra Gangi, Miguel Burch, Pareen Mehta,[...]. Diseases 2022
0


Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
Giandomenico Roviello, Giuseppe Aprile, Alberto D'Angelo, Luigi Francesco Iannone, Franco Roviello, Karol Polom, Enrico Mini, Martina Catalano. Gastric Cancer 2021
6

Trastuzumab deruxtecan for the treatment of HER2-positive gastric cancer.
Saori Mishima, Kohei Shitara. Expert Opin Biol Ther 2021
2

HER2-targeted therapies in gastric cancer.
Yinxing Zhu, Xuedan Zhu, Xiaowei Wei, Cuiju Tang, Wenwen Zhang. Biochim Biophys Acta Rev Cancer 2021
16

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, Davide Bosso, Laura Attademo, Cinzia Cardalesi, Anna Diana, Antonietta Fabbrocini, Teresa Fabozzi, Pasqualina Giordano,[...]. J Clin Med 2021
4

Hopes and failures in front-line advanced HER2-positive gastric cancer therapy.
Fanming Kong, Yang Yao, Renfen Deng, Xiaojiang Li, Yingjie Jia. Anticancer Drugs 2021
0



Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
Daniel V Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J Klempner, Zev A Wainberg, Manish A Shah, Sun Young Rha, Atsushi Ohtsu, Astra M Liepa,[...]. Oncologist 2021
2